Cargando…

SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males

BACKGROUND: Somatostatin receptor 2 (SSTR2) encodes somatostatin receptor that can inhibit the cell proliferation of solid tumors. Promoter hypermethylation is likely to silence the expression of SSTR2. The goal of our study was to investigate the association between SSTR2 promoter methylation and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Zhisen, Chen, Xiaoying, Li, Qun, Zhou, Chongchang, Li, Jinyun, Ye, Huadan, Duan, Shiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722764/ https://www.ncbi.nlm.nih.gov/pubmed/26796520 http://dx.doi.org/10.1186/s13000-016-0461-y

Ejemplares similares

The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2018)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

tRNA(Ini) (CAT) inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells
por: Li, Jun, et al.
Publicado: (2021)

Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer
por: Li, Jinyun, et al.
Publicado: (2020)

Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
por: Chen, Cheng, et al.
Publicado: (2013)

Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma
por: Wang, Baoshan, et al.
Publicado: (2019)

ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis
por: Shen, Zhisen, et al.
Publicado: (2018)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma
por: Huang, Chuang, et al.
Publicado: (2016)

Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis
por: Huang, Tao, et al.
Publicado: (2016)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

Long non-coding RNA AC023794.4-201 exerts a tumor-suppressive function in laryngeal squamous cell cancer and may serve as a potential prognostic biomarker
por: Shen, Zhisen, et al.
Publicado: (2020)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Expression of the long noncoding RNA RP11‐169D4.1‐001 in Hypopharyngeal Squamous cell carcinoma tissue and its clinical significance
por: Shen, Zhisen, et al.
Publicado: (2019)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma
por: Yang, Min, et al.
Publicado: (2012)

Hypermethylation of protocadherin γ subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer
por: Zhang, Cheng, et al.
Publicado: (2018)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
por: Shen, Yiming, et al.
Publicado: (2022)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC
por: Shen, Zhisen, et al.
Publicado: (2014)

Zinc finger E-box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

Promoter Specific Methylation of SSTR4 is Associated With Alcohol Dependence in Han Chinese Males
por: Zhao, Rongrong, et al.
Publicado: (2022)

mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015)

A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65
por: Ma, Hongying, et al.
Publicado: (2018)

CDKN2A methylation in esophageal cancer: a meta-analysis
por: Zhou, Chongchang, et al.
Publicado: (2017)

The effect of strength and endurance training on SSTR2 and SSTR5 in patients with colorectal cancer
por: Zanjani, Farhad Safari, et al.
Publicado: (2019)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
por: Deng, Hongxia, et al.
Publicado: (2023)

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9
por: Lv, Yuan, et al.
Publicado: (2019)

Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
por: Deng, Hongxia, et al.
Publicado: (2022)

Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines
por: Ye, Meng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_166hgqncpca52qk8igfrbbrsal